Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

Pain is a widespread problem across the world. More than 25% of the total population suffers from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its management presents a considerable challenge for physicians. Inadequate pain control remains a major problem across the world. There is an urgent and unmet need to manage these pain-related problems accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In many cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is primarily due to the absence of a perfect pain management solution. For more information visit: Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline

Pain management can be most effective only when the underlying disease conditions are cured. However, there is no treatment that offers absolute relief for the indications covered in this report. The medications given for these indications are more for modifying the disease symptoms than offering complete relief from pain. The combination of under-managed pain, low awareness, and fear of addiction to some classes of pain medication is preventing people suffering pain from seeking treatment 100% of the time.

Spanning over 186 pages, 94 tables and 85 figures, “Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline” report presents an in-depth assessment of the global pain management therapeutics market till 2019.

In addition to covering the market overview, market landscape, key geographies like Asia Pacific and China, competitive landscape and strategic insights the report also presents comprehensive forecasts for the market till 2019. The report covers 7 key industry players namely Pfizer Inc, Johnson & Johnson, Endo Pharmaceuticals, Forest Laboratories, Eli Lilly, Teva Pharmaceuticals (Cephalon, Inc.) and Purdue Pharma.

To browse more therapeutic market research reports visit: Therapeutic Market Research Reports